Search Results for 'astellas'
-
Bio News | Breaking News | Collaborations & Alliances | Industry News
Astellas Partners with LabCentral for ‘Golden Ticket Competition’
Provides access to life-science incubator and in-house Astellas expertise.Contract Pharma Staff 07.23.20
-
-
Breaking News | Drug Development | Industry News
Astellas, Seattle Genetics PADCEV Gains Breakthrough Designation
In combination with Merck's anti-PD-1 therapy KEYTRUDA for the treatment of advanced or metastatic urothelial cancer02.19.20
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development
Astellas, Adaptimmune Enter CAR-T Alliance
Aims to develop new stem-cell derived allogeneic T-cell therapies to treat cancer01.14.20
-
Drug Development | Industry News
Astellas Acquires Xyphos Biosciences
Gains novel and proprietary ACCEL (Advanced Cellular Control through Engineered Ligands) technology platform01.02.20
-
Trials & Filings
XTANDI Approved for mCSPC
The first oral treatment in three distinct types of advanced prostate cancer –non-metastatic and metastatic castration-resistant prostate cancer (CRPC).Astellas 12.17.19
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Drug Discovery | Industry News
Astellas to Fund Boston-Area Cell and Gene Therapy Start-Up
Invests $12.5 million to support LabCentral Incubators in Boston's Life Science Community10.01.19
-
Promotions & Moves
Astellas Appoints SVP and Head Clinical and Research QA
Fryrear, brings more than 30 years of pharmaceutical industry experience, holding senior leadership roles at AbbVie and Eli Lilly08.06.19
-
Top 25 Pharma and Biopharma Companies
(Based on 2018 Pharma/Biopharma Sales, in $U.S. Millions)Tim Wright & Kristin Brooks 07.18.19
-
Astellas, Frequency Therapeutics Enter Alliance for Hearing Loss Treatment
Aims to develop and commercialize Frequency’s candidate, FX-322, for the treatment of sensorineural hearing loss07.17.19
-
-
-
-
The Top Companies Report
Combined sales for 2018 topped the $600 billion markTim Wright, Editor 07.15.19
-
Astellas Appoints National Oncology Sales VP
Chelsea Glinski is recognized by the Healthcare Businesswomen's Association (HBA) as a 2019 Luminary07.10.19
-
APIs | Breaking News | Industry News
-
Promotions & Moves
Astellas Makes Senior-level Appointments
Benner named president and head of development, Guan named senior vice president and head of Medical Affairs04.04.19
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Industry News
ReForm Biologics, Astellas Form Collaboration
Will use ReForm’s technology to help progress Astellas’ biologics pipeline03.06.19
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
CytomX Acquires Agensys’ CD3-based Bispecific Technologies
Transaction provides novel payloads and CD3 binding moieties for next wave of potent anti-cancer agents01.07.19
-
Breaking News | Drug Development | Industry News
Astellas Pharma Acquires Potenza Therapeutics
Successful collaboration results in three INDs with the potential to treat various cancers12.17.18
-
Industry News | Promotions & Moves
Astellas Announces Key Promotion
Geoff Towle has been promoted to vice president, Oncology Marketing, Astellas US09.19.18
-
Promotions & Moves
Astellas Appoints Latin America VP
Fernandez responsible for leading operations and growth across Latin America08.24.18
-
Drug Development | Industry News
-
Bio News | Industry News | Promotions & Moves
Astellas Announces Management Changes
The changes include the positions of VP, Oncology, Medical Affairs, and VP, & executive director, Corporate Communications07.24.18
-
Top 25 Pharma and Biopharma Companies
Combined sales for 2017 reached $599 billion. (Based on 2017 Pharma/Biopharma Sales, in $U.S. Millions)07.23.18
-
-
-
cGMP Manufacture | Collaborations & Alliances | Drug Development | Facilities | Industry News
Eurofins, Astellas Sign Outsourcing Agreement
Astellas has committed to provide ASL work covering its current capacity for an agreed period of time05.29.18
-
Biologics, Proteins, Vaccines | Drug Development | Industry News
Kite Pharma Continues Expansion Efforts
New facilities will support cell therapy R&D and manufacture05.15.18
-
Breaking News | Collaborations & Alliances | Drug Discovery | Industry News | R&D
Actinium, Astellas Form Research Partnership
Will utilize Actinium's AWE Technology Platform to generate Actinium Radio-Conjugates on selected Astellas targeting agents03.29.18
-
Promotions & Moves
Astellas Appoints Ethics & Compliance Head
Dragovic to oversee Ethics & Compliance efforts globally03.28.18
-
Drug Development | Trials & Filings
Astellas Achieves Breakthrough Designation for Urothelial Cancer ADC
Enfortumab vedotin is being evaluated in metastatic urothelial cancer in patients previously treated with CPIs03.26.18
-
Promotions & Moves
Astellas Pharma Names Americas Ops President
Barretto-Ko to lead the company's North and South America operations03.15.18
-
Bio News | Drug Development | Promotions & Moves
-
Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Astellas Acquires Universal Cells
For a payment of up to $102.5 million of upfront and milestones02.14.18
-
Promotions & Moves
Astellas Makes Leadership Changes in Canada and U.S.
Sabus appointed GM of Astellas Pharma Canada; Gerber and O'Keefe promoted to new roles in U.S. sales organization01.09.18
-
Promotions & Moves
Astellas Names Americas Finance VP
Fiordaliso to oversee managerial reporting and budgeting, financial planning and analysis, revenue forecasting12.13.17
-
Promotions & Moves
Astellas Names GM for Brasil Ops
Britto brings more than 25 years of pharmaceutical industry experience12.05.17
-
Breaking News | Clinical Trials | Drug Development | Drug Discovery | Industry News
Astellas Buys Mitobridge in $450M Deal
Accelerates the discovery and development of drugs for mitochondrial function12.04.17
-
-
Promotions & Moves
Astellas Appoints RWI VP
Crisel responsible for overseeing Real World Informatics & Analytics11.02.17
-
Promotions & Moves
Astellas Appoints Specialty, Medical Affairs VP
Thal will assume overall responsibility for the strategic direction of the Specialty product portfolio10.31.17
-
Bio News | Breaking News | Facilities | Industry News
Seattle Genetics Buys Bothell Mfg. Facility from BMS
Facility provides manufacturing capacity and flexibility to support growing pipeline08.03.17
-
Clinical Trials | Drug Development | Promotions & Moves
Astellas Appoints Three Senior Development Heads
Fleishaker, Gronen, and Krivoshik to lead clinical, data, and oncology departments05.01.17
-
Breaking News | Promotions & Moves
Astellas Names President of Astellas US Technologies
John DeMay will be responsible for collaboration and cooperation across pharmaceutical technology divisions04.04.17
-
Drug Development | Industry News
-
Biologics, Proteins, Vaccines | Collaborations & Alliances
Astellas, Affinivax in Global MAPS Vax Pact
To develop and commercialize a vaccine targeting pneumococcus02.28.17
-
Drug Development | Industry News
Astellas Pharma to Acquire Ganymed
Adds several oncology assets in preclinical and clinical development10.31.16
-
Promotions & Moves
Astellas Expands Oncology Leadership
Brenner responsible for global leadership for Oncology, Keating responsible for all phases of Clinical programs10.05.16
-
Breaking News | Facilities | Industry News
Avara Acquires Astellas U.S. Manufacturing Facility
Will continue to manufacture certain Astellas pharmaceutical products on a contract basis08.09.16
